Active Coxsackieviral B infection is associated with disruption of dystrophin in endomyocardial tissue of patients who died suddenly of acute myocardial infarction.
OBJECTIVE
In this study, we evaluated the potential direct role of enterovirus (EV) cardiac infections in the pathogenesis of myocardial infarction (MI).


BACKGROUND
Enteroviruses (Picornaviridae) have been suspected to play a role in the development of acute MI.


METHODS
The presence of EV ribonucleic acid (RNA) sequences and capsid viral protein 1 (VP1) and the virus-mediated focal disruption of dystrophin were retrospectively investigated by reverse transcriptase-polymerase chain reaction and immunohistochemistry assays in endomyocardial tissues of patients who died suddenly of acute MI by comparison with similar samples of control patients matched for gender, residence area, and year of death.


RESULTS
Enterovirus infection markers were detected in 20 (40%) of 50 patients who died suddenly of MI, 2 (4%) of 50 matched subjects without cardiac disease (p < 0.001), and 4 (8%) of 50 matched patients exhibiting a noncoronary chronic cardiopathy (p < 0.001). All of the EV RNA-positive patients exhibited VP1, which provided evidence of viral protein synthesis activity. The VP1 gene sequences amplified after cloning from myocardial or coronary samples of 8 of the MI patients and showed a strong homology with sequences of coxsackievirus B2 and B3 serotypes. Moreover, in the endomyocardial tissue of these 8 patients, immunohistochemical analyses demonstrated that there was disruption of the sarcolemmal localization of dystrophin in the same tissue areas that were infected by coxsackieviruses.


CONCLUSIONS
Our findings demonstrate a significantly higher proportion of active coxsackievirus B cardiovascular infections in patients who suddenly died of MI compared with matched control subjects, suggesting that these EVs may significantly contribute to the pathogenesis of acute MI by a focal disruption of the dystrophin-glycoprotein complex.
Andréoletti
Laurent
L
Laboratoire de Virologie Médicale et Moléculaire et Faculté de Médecine (EA-3798), Centre Hospitalier Universitaire, Reims, France. landreoletti@chu-reims.fr
Ventéo
Lydie
L
Douche-Aourik
Fatima
F
Canas
Frédéric
F
Lorin de la Grandmaison
Geoffroy
G
Jacques
Jérôme
J
Moret
Hélène
H
Jovenin
Nicolas
N
Mosnier
Jean-François
JF
Matta
Mathieu
M
Duband
Sébastien
S
Pluot
Michel
M
Pozzetto
Bruno
B
Bourlet
Thomas
T
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D036022:Capsid Proteins / Q000378:metabolism; D016022:Case-Control Studies; D016757:Death, Sudden, Cardiac / Q000209:etiology; D016189:Dystrophin / Q000378:metabolism*; D004699:Endocardium / Q000378:metabolism / Q000821:virology*; D029822:Enterovirus B, Human / Q000235:genetics / Q000302:isolation & purification*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000378:metabolism* / Q000401:mortality / Q000821:virology*; D012367:RNA, Viral / Q000378:metabolism*
D036022:Capsid Proteins; D016189:Dystrophin; D012367:RNA, Viral